Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eukaryotic translation initiation factor 4H pseudogene 2 (EIF4HP2) is a human pseudogene listed in gene nomenclature resources as a non-protein coding DNA sequence related to the eukaryotic translation initiation factor 4H gene family[1][4][7]. The locus type is classified as "pseudogene," meaning it does not code for a functional protein and thus cannot serve as a drug or therapeutic target. No aliases, functional products, roles in disease, or interactions with drugs have been identified for this pseudogene. Its primary relevance is limited to genomics annotation, and it is not involved in translation initiation or disease biology. EIF4HP2 should not be mistaken for EIF4H (the functional gene encoding a translation initiation factor), or for EIF4A or related functional translation factors which are actually subject to pharmacological interest[2]. Pseudogenes like EIF4HP2 may have regulatory RNA effects in some cases, but there is no evidence or documentation that EIF4HP2 has such a role. This entity is not a molecular target for therapeutics or biomarker development.
None (Not a protein, enzyme, or receptor; no mechanism)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation initiation factor 4H pseudogene 2 (EIF4HP2).